Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

[Impact of introducing rifampicin for the treatment of tuberculosis during the 1970's in Japan].

Mori T, Uchimura K, Shimao T.

Kekkaku. 2013 Apr;88(4):417-22. Japanese.

PMID:
23819318
[PubMed - indexed for MEDLINE]
2.

[Research and control of relapse tuberculosis cases].

Yamagishi F, Toyota M.

Kekkaku. 2009 Dec;84(12):767-8. Japanese.

PMID:
20077861
[PubMed - indexed for MEDLINE]
3.

[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].

Wada M.

Kekkaku. 2001 Jan;76(1):33-43. Review. Japanese.

PMID:
11211781
[PubMed - indexed for MEDLINE]
4.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
[PubMed - indexed for MEDLINE]
5.

[Anti-tuberculosis chemotherapy].

Wada M.

Kekkaku. 2007 Oct;82(10):771-81. Review. Japanese.

PMID:
18018601
[PubMed - indexed for MEDLINE]
6.

[Trends in tuberculosis treatment duration].

Veziris N, Aubry A, Truffot-Pernot C.

Presse Med. 2006 Nov;35(11 Pt 2):1758-64. Review. French.

PMID:
17086138
[PubMed - indexed for MEDLINE]
7.

[Reform of Japan's NTP and its technical perspectives].

Mori T.

Kekkaku. 2004 Oct;79(10):587-604. Review. Japanese.

PMID:
15631111
[PubMed - indexed for MEDLINE]
8.

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.

Rosenthal IM, Zhang M, Williams KN, Peloquin CA, Tyagi S, Vernon AA, Bishai WR, Chaisson RE, Grosset JH, Nuermberger EL.

PLoS Med. 2007 Dec;4(12):e344.

PMID:
18092886
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.

Zhang T, Zhang M, Rosenthal IM, Grosset JH, Nuermberger EL.

Am J Respir Crit Care Med. 2009 Dec 1;180(11):1151-7. doi: 10.1164/rccm.200905-0795OC. Epub 2009 Sep 3.

PMID:
19729664
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, Vernon A, Lienhardt C, Burman W.

PLoS Med. 2009 Sep;6(9):e1000146. doi: 10.1371/journal.pmed.1000146. Epub 2009 Sep 15. Review.

PMID:
19753109
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Tuberculosis annual report 2010--(9) Treatment of tuberculosis-2].

Tuberculosis Surveillance Center; RIT; JATA.

Kekkaku. 2013 Apr;88(4):439-43. Japanese.

PMID:
23819321
[PubMed - indexed for MEDLINE]
12.

[The effectiveness of pyrazinamide-containing six-month short course chemotherapy].

Wada M.

Kekkaku. 2000 Nov;75(11):665-73. Japanese.

PMID:
11140090
[PubMed - indexed for MEDLINE]
13.

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

Elsherbiny D, Cohen K, Jansson B, Smith P, McIlleron H, Simonsson US.

Eur J Clin Pharmacol. 2009 Jan;65(1):71-80. doi: 10.1007/s00228-008-0481-y. Epub 2008 Aug 27.

PMID:
18751690
[PubMed - indexed for MEDLINE]
14.

Rates and risk factors for discontinuation of rifampicin.

Cook SV, Fujiwara PI, Frieden TR.

Int J Tuberc Lung Dis. 2000 Feb;4(2):118-22.

PMID:
10694089
[PubMed - indexed for MEDLINE]
15.

[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].

Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.

Probl Tuberk Bolezn Legk. 2004;(3):32-7. Russian.

PMID:
15338898
[PubMed - indexed for MEDLINE]
16.

Estimate of the global market for rifampicin-containing fixed-dose combination tablets.

Norval PY, Blomberg B, Kitler ME, Dye C, Spinaci S.

Int J Tuberc Lung Dis. 1999 Nov;3(11 Suppl 3):S292-300; discussion S317-21.

PMID:
10593708
[PubMed - indexed for MEDLINE]
17.
18.

[Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].

Khodashova ML, Iuditskiń≠ MV, Semenova OV.

Probl Tuberk Bolezn Legk. 2004;(3):26-8. Russian.

PMID:
15338896
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.

Avihingsanon A, van der Lugt J, Singphore U, Gorowara M, Boyd M, Ananworanich J, Phanuphak P, Burger D, Ruxrungtham K.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1170-6. Epub 2012 Mar 6.

PMID:
22250979
[PubMed - indexed for MEDLINE]
20.

[Case report--tuberculosis in a health care worker during pregnancy].

Peters C, Nienhaus A.

Pneumologie. 2008 Nov;62(11):695-8. doi: 10.1055/s-2008-1038264. Epub 2008 Oct 14. German.

PMID:
18855309
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk